No Cover Image

Journal article 105 views 20 downloads

Semaglutide improves health‐related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6) / Esteban Jódar; Marie Michelsen; William Polonsky; Rosangela Réa; Anna Sandberg; Tina Vilsbøll; Mark Warren; Signe Harring; Uwe Ziegler; Steve Bain

Diabetes, Obesity and Metabolism

Swansea University Author: Steve, Bain

  • 54313VOR.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution‐NonCommercial License (CC-BY-NC).

    Download (1.08MB)

Check full text

DOI (Published version): 10.1111/dom.14039

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54313
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: cardiovascular disease, GLP-1 analogue, hypoglycaemia, incretin therapy, type 2 diabetes,weight control